Fig. 5From: Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysisPooled hazard ratio for HCC incidence between TDF and ETV treatments in CHB patientsBack to article page